should glp-1 agonists be open access receptor GLP-1 Agonists For Obesity In
Description
Femminella GD, Livingston NR, Raza S, van der Doef T, Frangou E, Love S, et al
doi: 10.1007/s00125-010-1896-4
Cardiovasc Diabetol 24 , 87 (2025)
A tablet form of the semaglutide-based drug Wegovy was given the go-ahead in January
The new study found a lower risk for aspiration pneumonia in patients taking GLP-1 medications, compared with people who didnt
